Loading stock data…
Prenetics Global Limited (PRE)
$18.58-0.25 (-1.33%)
Market ClosedLast close Jun 29
Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Prenetics Global Limited in the Healthcare sector is trading at $18.58 with a market capitalization of $350M. Wall Street consensus targets $31.00 (5 analysts), implying a +66.8% move over the next 12 months. The stock is currently 21% below its 52-week high of $23.63, remaining 10.7% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +66.8% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Total Revenue | $36.56M↑ | $23.55M↑ | $17.68M↑ | $17.31M↑ | $10.49M |
| Gross Profit | $21.59M↑ | $14.02M↑ | $7.29M↓ | $7.34M↑ | $3.90M |
| Operating Income | -$13.14M↓ | -$6.56M↑ | -$9.87M↑ | -$10.94M↑ | -$17.86M |
| Net Income | -$7.50M↓ | -$7.41M↑ | -$12.41M↓ | -$10.39M↑ | -$16.34M |
Peer Comparison
JNJUNHPFE
Fundamentals
Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$350.46M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-24.10%
Volume
Today's trading volume
85,947
Recent News
Prenetics Global Limited (PRE) Receives Bullish Coverage as IM8 Targets Supplement Market Growth
We recently compiled a list of the 10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds. Prenetics Global Limited (NASDAQ:PRE) is one of the most promising stocks on our list. TheFly reported on June 16 that Benchmark initiated coverage of PRE with a Buy rating and a $30 price target. The firm highlighted the company’s […]
Sector Update: Healthcare Stocks Decline Late Afternoon
Healthcare stocks fell late Wednesday afternoon with the NYSE Healthcare Index declining 0.8% and th
Prenetics Starts Partnership with Jay Shetty as IM8 Global Ambassador & Shareholder
By Karen Roman Prenetics Global Limited (Nasdaq: PRE) confirmed its multi-year partnership with #1 New York Times bestselling author and award-winning podcast host of On Purpose, Jay Shetty, making him […]
Prenetics Global Ltd (PRE) Q1 2026 Earnings Call Highlights: Record Revenue Surge Amid ...
Prenetics Global Ltd (PRE) reports a 333% revenue increase but faces operational losses and strategic uncertainties.
Prenetics Global Q1 Earnings Call Highlights
Prenetics Global (NASDAQ:PRE) said its first-quarter results reflected the company’s shift away from diagnostics and genome testing toward a subscription-driven consumer health model anchored by its IM8 supplement brand. Chief Executive Officer and Co-Founder Danny Yeung told investors that IM8, la